Weekly roundup
Hey wellness warriors,
Kim K’s trainer Senada Greca just launched a supplement line designed to kill “pill clutter.”
Meanwhile, Calm teamed up with Ozlo Sleepbuds to reinvent rest. And J&J dropped major new data that could reshape chronic disease care.
Plus: Tom Holland’s alcohol-free beer just partnered with Aston Martin.
🚀 Brand Spotlight
Kim K's Trainer Just Solved the Supplements Problem
Celebrity trainer Senada Greca (yes, the one who trains Kim Kardashian) just launched a new supplement brand called Aonic—and it’s designed to end “pill clutter” for good.
Source: Aonic
The star product, Aonic Complete ($115 / 30 days), uses a dual-chamber bottle that delivers your entire daily routine in 30 seconds:
Aonic’s formulas were developed with Harvard-trained Dr. David Jan, adding real scientific credibility.
Why it matters:
Aonic simplifies supplements into one premium, personalized system, standing out in a crowded market where most people feel overwhelmed by options.
🚀 Brand Spotlight
Your Favorite Meditation App Just Got Into Your Ears
Ozlo has partnered with Calm (announced November 13th), bringing Calm’s signature Sleep Stories and soundscapes directly into Ozlo’s next-gen Sleepbuds—now in a new “Calm Blue” edition.
Source: Ozlo
Ozlo handles the hardware with noise-masking audio and sleep-focused design, while Calm brings its world-famous relaxation library.
iOS users get a free year of Calm Sleep, and Android users get Calm Premium.
This collab signals the future of wellness: seamless ecosystems where hardware and content work together to deliver personalized, restorative rest.
Calm has dominated the app space; now it’s moving into your ears—and into the booming $480B wellness market.
🔬 Research Radar
J&J Sets a New Standard for Chronic Disease Treatment
Johnson & Johnson just released major new clinical data that could change how psoriatic arthritis (PsA) is treated.
Long-term results from the Phase 3b APEX study (presented November 17th) show that TREMFYA® (guselkumab) is currently the only IL-23 inhibitor proven to significantly slow structural joint damage in active PsA.
The big takeaway: TREMFYA reduced the rate of joint damage progression by 57% for patients who switched from placebo—and this protection held strong through 48 weeks.
This matters because PsA isn’t just joint pain. It’s a chronic inflammatory condition tied to fatigue, obesity, and cardiovascular risk.
A drug that preserves joint structure gives patients a real shot at protecting long-term function and quality of life.
J&J is now seeking FDA approval to update the drug label, which could set a new expectation for PsA treatment: joint preservation, not just symptom relief.
In case you missed it
💡 Quick Hits
Cheap Gout Drug May Slash Heart Attack Risk. A surprising study found that the inexpensive, commonly prescribed gout medication colchicine significantly reduced the risk of heart attacks and strokes in patients with stable coronary disease. This finding offers a major, accessible tool for preventative cardiac wellness.
Celebrity/Brand Partnership Elevates Sleep. Hilton and mental wellness app Calm partnered with influencer Paige DeSorbo to launch an exclusive Sleep Story. Recorded at the Waldorf Astoria New York, the collaboration blends celebrity influence with the "soft life" self-care trend, positioning luxury rest as a core wellness ritual.
Tom Holland's BERO Partners with Aston Martin. BERO announced a three-year partnership with Aston Martin on November 12th, making it the official alcohol-free beer partner of the British luxury car manufacturer. BERO will be visible at Aston Martin events globally, cementing nonalcoholic beer's evolution from wellness niche to luxury lifestyle choice.
That’s it for this week.
From high-performance supplements to digital balance and luxury rest, wellness is getting smarter, calmer, and more connected.
Stay curious,
The Wellness Radar Team
Social
Check Out Our YouTube Video!
3 Easy Recipes That Are Actually Healthy for You
💭 Help Shape the Future of Wellness Radar
Got two minutes? We’d love your quick feedback to make Wellness Radar even better—more stories you care about, fewer you don’t.
👉 Click Here to take the short survey